Venture capital investors may not be hitting the pause button entirely on startup investments, but the landscape saw a noticeable cooling off in giant, multi-hundred-million-dollar rounds this past week. While capital continues to flow heavily into high-conviction sectors like artificial intelligence, biotechnology, and specialized infrastructure, only two startups managed to secure financing rounds in the multiple hundreds of millions of dollars.
The week’s largest influx of capital went to AI infrastructure provider Modal Labs, which pulled in a staggering $750 million. Trailing at a distance was construction automation unicorn Icon, which secured a respectable $200 million. Beyond these two massive flagships, investor attention was spread across a diverse mix of sectors, with biotech, healthcare AI, insurance, and semiconductor systems also capturing significant market share during a selective week for venture capital deployment.
The Giants of the Week: Modal Labs and Icon Take Center Stage
At the very top of the funding leaderboard sits Modal Labs, a prominent provider of cloud infrastructure designed specifically for AI inference and other computationally demanding workloads. Based in New York, Modal Labs closed an enormous $750 million Series D funding round led by Accel. The massive investment values the company at an eye-watering $15.75 billion. The capital injection comes on the heels of impressive financial milestones for the infrastructure provider, with Modal Labs reporting that it recently surpassed an annual revenue run rate of $1 billion, underlining the insatiable enterprise demand for scalable AI backend solutions.
Coming in second for the week is Austin, Texas-based Icon. A recognized pioneer in robotic construction systems best known for its innovative 3D-printed homes, Icon successfully closed a $200 million Series D financing round. The round was co-led by institutional heavyweights Baillie Gifford and BlackRock. Icon’s latest capital raise is fueled by strong commercial momentum, with the construction tech unicorn reporting that it is currently on a rapid trajectory toward quadrupling its revenue through 2026.
Biotech and Genetic Medicines Capture Significant Capital
While AI dominated the headline-grabbing valuations, the biotechnology sector quietly commanded some of the week’s most substantial venture investments, particularly in the realm of advanced therapeutics and genetic medicines.
Boston-based Soufflé Therapeutics emerged with $135 million in a Series B funding round. The developer of cutting-edge RNA therapies secured the backing from a large syndicate of investors led by the Juvia Group. RNA therapeutics continue to attract major investor enthusiasm as venture firms look for long-term clinical breakthroughs capable of addressing diseases previously thought to be undruggable.
West Coast biotech also saw a major launch. Menlo Park, California-based Estuary Biotherapeutics officially stepped out of stealth mode with a total of $103 million in financing dedicated to developing novel genetic medicines for patients suffering from serious and degenerative kidney diseases. The impressive launch capital includes $93 million in a Series A round led by RA Capital Management, alongside $10 million in previously undisclosed seed capital that helped lay the groundwork for the company’s platform.
Expanding AI Applications, Health Tech, and Caregiver Platforms
Artificial intelligence continues to permeate nearly every layer of the enterprise technology stack, moving beyond raw infrastructure into specialized evaluation tools and verticalized workflows.
Labelbox, a San Francisco-based developer of technology used to train, evaluate, and deploy AI models and autonomous agents that improve dynamically through user interaction and experience, secured $100 million in Series E funding. The financing for the eight-year-old company was led by Infinitum Partners, reflecting ongoing institutional confidence in the data-labeling and model-tuning ecosystem essential to enterprise AI adoption.
Healthcare AI also secured a prominent spot on the weekly roundup. Redwood City, California-based Suki announced a $90 million Series E funding round. Suki specializes in ambient AI tools that transform complex clinical conversations into actionable medical intelligence, streamlining electronic health record documentation, medical coding, and other administrative workflows for overburdened healthcare providers. Backers for the round included Healthier Capital and Crosslink Capital.
In the broader health and care economy, Abby Care closed an $82 million Series C funding round led by Transformation Capital, according to recent industry reports. The five-year-old, San Francisco-based startup operates a specialized platform that enables family members to become certified, paid professional caregivers capable of delivering specialized, high-quality care directly within the home environment.
Niche Markets: Insurance, Semiconductors, and Infrastructure Spend Intelligence
Rounding out the top ten largest funding deals of the week were ventures addressing specific enterprise pain points in climate risk, hardware architecture, and cloud spend management.
Stand, a San Francisco-based insurtech startup focusing on residential property insurance for homes located in regions facing heightened risks of natural disasters, secured $70 million in Series C funding. The financing values the three-year-old company at the coveted $1 billion unicorn threshold, with Saga Ventures Management leading the round as insurers grapple with escalating climate-related payout risks.
In hardware and compute infrastructure, Portland, Oregon-based Mueon Corp. completed a $65 million Series A funding round. Mueon is building a modular semiconductor systems platform designed to support the intense demands of modern AI and hyperscale computing architectures. The financing was led by Maverick Silicon.
Finally, New York-based North.cloud rounded out the list with a $60 million Series B funding round led by PeakSpan Capital. The company provides a specialized infrastructure spend intelligence and automation platform designed to help enterprises monitor, analyze, and optimize mounting cloud and AI infrastructure expenditures.
Methodology
The data for this weekly market overview is compiled by tracking the largest announced venture capital funding rounds in the Crunchbase database raised by United States-based companies. The tracked period for this report covers transactions announced between October 10 and October 16, 2026. While the database captures the vast majority of publicly announced venture activity, minor reporting time lags can occasionally occur for deals disclosed late in the weekly cycle.
